The research breakthrough ends decades of failure and shows a new era of drugs to treat Alzheimer's - the most common form of dementia - is possible.
Yet the medicine, lecanemab, has only a small effect and its impact on people's daily lives is debated.
And the drug works in the early stages of the disease, so most would miss out without a revolution in spotting it. BBC News
See also:
- Lecanemab in Early Alzheimer’s Disease (abstract) New England Journal of Medicine
- Everything you need to know about 'breakthrough' Alzheimer's drug lecanemab The Daily Mail
- New Alzheimer´s drug hailed as 'beginning of the end' in search for treatment The Daily Mail
- Drug slows cognitive decline in Alzheimer’s patients, study reveals The Guardian
- NHS ‘nowhere near ready’ to deliver new Alzheimer’s drug, doctors say The Guardian
- Second death linked to potential antibody treatment for Alzheimer’s disease Science
- Lecanemab: New Alzheimer's drug slows decline in memory - fuelling hope doctors will one day cure dementia Sky News
No comments:
Post a Comment